It is unlikely that GLP-1 agonists themselves are directly responsible for the acne that some patients may develop during treatment, the study authors note
Maintaining the FDA-approved weekly dosing schedule provides the most predictable efficacy and safety profile based on clinical trial evidence
Combat GLP-1 and diet-related fatigue The Wegovy (semaglutide) patient information label by Novo Nordisk states that 11% of adults taking Wegovy 2.4 mg experience fatigue, and 8% felt dizzy
Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial [press release]
We nemen de tijd, luisteren, onderzoeken zorgvuldig en geven een eerlijk advies
The pea protein isolate is readily soluble and can improve the creaminess of products without adding fat